Manufacturer record
Empree medicaments India Private Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Empree medicaments India Private Limited (Karnataka) was declared Not of Standard Quality in March 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: L2310099, Terbutaline Sulphate, Bromhexine Hydrochloride, Guaiphenesin & Menthol Syrup (Esytus plus) (exp Sep 2025). CDL Kolkata (CDSCO lab) found it not of standard quality: Assay of Bromhexine Hydrochloride & Menthol. Listed in the March 2024 alert.
Records by type
1 record linked to Empree medicaments India Private Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Terbutaline Sulphate, Bromhexine Hydrochloride, Guaiphenesin & Menthol Syrup (Esytus plus) | Batch L2310099Mfg Oct 2023 · Exp Sep 2025 | Assay of Bromhexine Hydrochloride & MentholAssay | CDL KolkataCDSCO lab | Mar 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.